We could also show that genetic ablation of AdipoR2 slows down the progression of atherosclerosis in the brachiocephalic artery in atherosclerosis prone male mice lacking ApoE indicating that antagonizing AdipoR2 or activating AdipoR1 may be an attractive therapeutic approach for the treatment of atherosclerosis. This evidence concerns the gene ADIPOR2 and atherosclerosis.